Equity Details
Price & Market Data
Price: $1.31
Daily Change: +$0.03 / 2.29%
Daily Range: $1.28 - $1.31
Market Cap: $2,351,790
Daily Volume: 6,034
Performance Metrics
1 Week: -0.76%
1 Month: 6.50%
3 Months: -3.68%
6 Months: -25.14%
1 Year: -70.10%
YTD: -9.66%
About Bone Biologics Corporation (BBLG)
Summarized market data for Bone Biologics Corporation (BBLG). Price: 1.31, daily change: +$0.03 / 2.29%. Market cap: 2,351,790. Performance over 3-month and 6-month periods.
Company Details
Employees: 2
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.